Peak body representing the pharmaceutical industry welcomes new chief executive with lengthy experience in public service and environmental policy
Medicines Australia today announced the appointment of Milton Catelin as the new Chief Executive Officer of the organisation, replacing interim CEO Lee Hill who had been in the role since February.
“Milton Catelin is a fantastic appointment for Medicines Australia and on behalf of the members I congratulate him for taking on this important role for the innovative medicines industry,” said Medicines Australia Chairman Wes Cook.
Hill will be staying on at the organisation for the next few months to help to finalise the organisational restructure he has led with the board, said Cook.
Catelin has said he is honoured to have been chosen for the role.
“Medicines Australia plays such a crucial role in advocacy and policy development to ensure that the Australian community has fast, affordable access to the latest innovative medicines and vaccines,” he said.
“It will be a privilege to lead this important work on behalf of the members who are at the forefront of medical science innovation both in Australia and around the world.”
Milton returns to Australia after having spent 13 years in overseas roles including as Chief Executive of International Public Affairs (IPA) in London, Chief Executive of the World Coal Association (WCA), and Chief of Partnerships & Public Affairs with the United Nations Environment Programme (UNEP) in Geneva.
Before moving to Geneva, Milton had worked in Australian policy on ozone protection and climate change leading to an Australian Public Service Award for “significant and sustained contribution to the achievements of Environment Australia” in 2001.